Partners Capital Investment Group, LLP Bristol Myers Squibb CO Transaction History
Partners Capital Investment Group, LLP
- $3.34 Billion
- Q4 2024
A detailed history of Partners Capital Investment Group, LLP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Partners Capital Investment Group, LLP holds 88,770 shares of BMY stock, worth $5.23 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
88,770
Previous 170,975
48.08%
Holding current value
$5.23 Million
Previous $8.85 Million
43.26%
% of portfolio
0.15%
Previous 0.15%
Shares
12 transactions
Others Institutions Holding BMY
# of Institutions
2,602Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11.1 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.35 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.48 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.59 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.6 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $125B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...